戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  hydrochloride, 2-N-methylellipticinium, and berberine).
2  translation via utilizing a plant compound, berberine.
3 ill-in dGMP is covered and well-protected by berberine.
4 ex I-inhibiting interventions: metformin and berberine.
5 thelial cells line in vitro (Calu3 cells) by berberine.
6 ically important alkaloids: magnoflorine and berberine.
7 o oxidized forms, including (RS)-canadine to berberine.
8  translation via utilizing a plant compound, berberine.
9 iquid-to-solid ratio- 30 mL/g], the yield of berberine (11.91 +/- 0.12 mg/g DW), berbamine (11.85 +/-
10 t was shown to be defective in the efflux of berberine, a model antimicrobial plant chemical.
11  of PCSK9 can be blocked by the treatment of berberine, a natural cholesterol-lowering compound which
12                                              Berberine, a natural product derived from a plant used i
13                      The results showed that berberine administration at one time or before STZ-stimu
14           This pilot registry indicates that berberine administration is effective in reducing lipids
15 ed at clarifying the protective mechanism in berberine against islet cell apoptosis.
16     The first total synthesis of the dimeric berberine alkaloid ilicifoline (ilicifoline B) is report
17                                              Berberine alkaloids, which are cationic antimicrobials p
18                                              Berberine also reduced tumor-induced angiogenesis in vit
19                                              Berberine also suppressed the expression of NF-kappaB-re
20                    Here, we hypothesize that berberine ameliorates periodontal bone loss by improving
21                                              Berberine, an isoquinoline alkaloid derived from a plant
22                Previous studies suggest that berberine, an isoquinoline alkaloid, has shown various b
23                                              Berberine, an isoquinoline alkaloid, is a traditional or
24 e NMR structure can guide rational design of berberine analogues that target the PDGFR-B vG4 or dGMP-
25  four-electron oxidations of (S)-canadine to berberine and (S)-tetrahydropapaverine to papaverine.
26 alone but strongly potentiated the action of berberine and other NorA substrates against S. aureus.
27  with small molecules, such as the alkaloids berberine and palmatine and the DNA intercalator ethidiu
28 the relative intensities of the bands due to berberine and palmatine suggest that the ancient paper i
29 resis/mass spectrometry (CE/MS) detection of berberine and palmatine using the microsprayer.
30  resin as most effective for the recovery of berberine and palmatine, while, XAD-7HP resin is best su
31 berberine ursodeoxycholate, an ionic salt of berberine and ursodeoxycholic acid), versus placebo that
32        Putative triplex (BePI, coralyne, and berberine) and tetraplex [H(2)TmPyP, 5,10,15, 20-tetraki
33 orphine, the antimicrobials sanguinarine and berberine, and the vasodilator papaverine.
34 e bacterial resistance mechanism against the berberine antimicrobial.
35 ution, the binding mode and stoichiometry of berberine are substantially different from the crystal s
36 cals," including resveratrol, quercetin, and berberine, are also AMPK activators.
37 current study may lead to the development of berberine as an orally, active therapeutic against COVID
38                                              Berberine (BBR) is a natural compound with variable phar
39                                              Berberine (BBR) is a natural lipid lowering drug that re
40                                              Berberine (BBR) is an isoquinoline alkaloid from plants
41        Increasing evidence demonstrates that berberine (BBR) is beneficial for obesity-associated non
42                                              Berberine (BBR) is known for its therapeutic effect on o
43 e plant-derived hypocholesterolemic compound berberine (BBR) up-regulates LDLR expression while down-
44 microbiota like oral intake of probiotics or berberine (BBR), a bacteriostatic agent, merit metabolic
45 nt in the suppression of PCSK9 expression by berberine (BBR), a natural cholesterol-lowering compound
46 r cells, we observed that the plant compound berberine (BBR), a potent activator of AMP-activated pro
47 r cells, we observed that the plant compound berberine (BBR), a potent activator of AMP-activated pro
48                              Simvastatin and berberine (BBR), cholesterol synthesis inhibitors, effic
49 tures of BmrR bound to rhodamine 6G (R6G) or berberine (Ber) and cognate DNA.
50                                              Berberine (BER), a clinically important natural isoquino
51                               The supplement Berberine (Berbevis(TM) as Sophy((R)) tablets) was used
52 Gelatin (CA/Gel) electrospun mat loaded with berberine (Beri) as the DFU-specific wound dressing.
53                                              Berberine binding promotes RXRalpha interaction with nuc
54 sed on a previous crystal structure in which berberine binds as a dimer to a parallel G-quadruplex.
55 tially different from the crystal structure: berberine binds as a monomer to MycG4 using a base-recru
56 (S)-canadine synthase enzyme involved in the berberine biosynthesis pathway may play critical roles i
57 lution NMR structure of a ternary complex of berberine bound to the dGMP-fill-in PDGFR-B vG4 in potas
58   The effects of the well-tolerated alkaloid Berberine (BRB), used for treating metabolic disorders,
59 contain a large number of genes encoding for berberine bridge enzyme (BBE)-like enzymes.
60 l alcohol oxidase as reported previously for berberine bridge enzyme and other FAD-dependent oxidored
61 ium poppy stem transcriptome databases using berberine bridge enzyme yielded several candidate genes,
62                                              Berberine bridge enzyme-like (BBE-l) proteins named OG o
63 g of the pyrazinone ring by an FAD-dependent berberine bridge enzyme-like oxidoreductase has been pro
64                               Swapping these berberine bridge enzyme-like oxidoreductases, we produce
65 BLAST analysis identified the nec5 cDNA as a berberine bridge enzyme-like protein.
66  characterisation of a group of P. infestans berberine bridge enzyme-like proteins (BBEs) and their r
67 e lines by CRISPR/Cas9-based inactivation of berberine bridge enzyme-like proteins (BBLs).
68 (S)-tetrahydroprotoberberine oxidase and the berberine bridge enzyme.
69 fies RXRalpha as a direct protein target for berberine but also dissects their binding mode and valid
70 associated with the antimetastatic effect of berberine by showing a nearly complete inhibition on inv
71                                              Berberine cation (Ber(+)) found in Coscinium fenestratum
72  Of the non-flavonoid phytochemicals tested, berberine, celastrol, ellagic acid, limonin, oleanolic a
73                    All subjects managed with berberine completed the three-month registry.
74  retinoid X receptor alpha (RXRalpha), where berberine concomitantly binding to and synergistically a
75 y determination of a 2 ng/microL solution of berberine contained as a dry residue in the bottom of a
76 aken together, these findings suggested that berberine could reduce metastasis and angiogenesis of ce
77                               Significantly, berberine covers and stabilizes the fill-in dGMP.
78                                  G4-targeted berberine derivatives have been actively developed; howe
79 ructure-based rational design of G4-targeted berberine derivatives, and this study demonstrates that
80 e findings implied that the incorporation of berberine did not compromise the physical properties of
81                                 However, the berberine effect on pancreatic islets is still not clear
82                                 Furthermore, berberine enhances DNA methylation level in whole genome
83                                              Berberine extracted from Chinese medicinal plants has sh
84 toxic, 5 compounds (all-trans retinoic acid, berberine, fisetin, propranolol, and ritonavir) extended
85 ine into solution and consequently, quenched berberine fluorescence.
86 the OVX-periodontitis rats were treated with berberine for 7 wk before sacrifice for analyses.
87 MDR-dependent efflux of ethidium bromide and berberine from S. aureus cells was completely inhibited
88               Triglycerides decreased in the berberine groups (P<0.05) and the levels of CoQ10 remain
89                               In particular, berberine has a wide range of antiviral activities such
90                                              Berberine has several anti-inflammation and anticancer b
91 ence with a small molecule GQ-binding agent, berberine hydrochloride, further increased GQ stability.
92     The most potent apoptosis was induced by berberine in ALL cells with both MDM2 overexpression and
93 s significantly more decreased (P<0.05) with berberine in comparison with standard management.
94 us DUX4 confirmed the therapeutic effects of berberine in downregulating DUX4 protein expression, inh
95 ates the potential therapeutic mechanisms of berberine in preventing and treating COVID-19 and SARS u
96                 The level of accumulation of berberine in the cells was increased strongly in the pre
97 nificantly increased oral bioavailability of berberine, increased IFN-y production by CD8+ T cells, a
98 ssects their binding mode and validates that berberine indeed suppresses beta-catenin signaling and c
99                  Herein, we demonstrate that berberine induces apoptosis in acute lymphoblastic leuke
100                                              Berberine induces more apoptosis, cell cycle arrest, but
101               Here, we provide evidence that berberine inhibits beta-catenin function via directly bi
102                                    Moreover, berberine inhibits expressions of CAR and its target gen
103  of exonuclease I, leading to the release of berberine into solution and consequently, quenched berbe
104                               The binding of berberine involves both n-stacking and electrostatic int
105 sm of CAR metabolic pathway, suggesting that berberine is a promising candidate in anticancer adjuvan
106 tosis; and protecting against tissue damage, berberine is a promising candidate in preventing and tre
107  COVID-19 to be combined with other therapy, berberine is a promising orally administered therapeutic
108                          Here we report that berberine is able to be cellular uptake and accessible t
109                                              Berberine is an ancient multipotent alkaloid drug which
110                                              Berberine is an isoquinoline alkaloid used for its pharm
111                The medicinal natural product berberine is one of the most actively studied and pursue
112                                 Accordingly, berberine is protected in the G-quadruplex structure and
113 ynthesis of the biologically active alkaloid berberine is reported, and a versatile palladium-catalyz
114 aptamer (ATP-aptamer) and a DNA binding dye, berberine, is digested upon the addition of exonuclease
115 the dopamine D(3) receptor ligand, including berberine-like analogues.
116 nd anti-inflammatory activities displayed by berberine may be mediated in part through the suppressio
117 ults indicated that the antiproliferation of berberine might be mediated by the unique epigenetic mod
118 lex has a 2:1:1 binding stoichiometry with a berberine molecule bound at each the 5'- and 3'-end of t
119        An orally available immunotherapeutic-berberine nanomedicine, named NIT-X, has been developed
120  the high oral bioavailability and safety of berberine nanomedicine, the current study may lead to th
121  that downregulation of MDM2 in ALL cells by berberine occurred at a posttranslational level through
122  mice to unravel the protective mechanism of berberine on islets.
123 ese processes, we investigated the effect of berberine on this pathway.
124 cholesterol was significantly decreased with berberine (P<0.05) and HDL was significantly improved (P
125 arr units - was significantly decreased with berberine (P<0.05).
126 tion curves (2.5-100 pmol) for the standards berberine, palmatine, and hydrastinine spotted as a mixt
127 ch contains three major yellow chromophores: berberine, palmatine, and jatrorrhizine.
128            High-affinity substrates included berberine, pentamidine, and amisulpride, while epinephri
129                                         Each berberine recruits the adjacent adenine residue from the
130 itical roles in the diversification of other berberine-related alkaloids in C. chinensis.
131 ntracellular target mediating the effects of berberine remains elusive.
132 ciency-aggravated periodontal bone loss, and berberine represents a promising adjuvant therapeutic by
133                                              Berberine reversed transforming growth factor-beta1-indu
134 menclature) could efflux xenobiotics such as berberine, rhodamine 123, and paraquat.
135                     Our results suggest that berberine's anti-apoptotic effect on pancreatic primary
136                              We investigated berberine's pharmacological activities from the perspect
137                These findings highlight nano-berberine-starch as a promising strategy for multifuncti
138  was complexed with berberine to form a nano-berberine-starch complex and cast into active films.
139 ation and a subsequent upregulation of MDM2, berberine strongly induced persistent downregulation of
140 ical area) was significantly decreased after berberine supplementation (P<0.05).
141  fat proportion also decreased (P<0.05) with berberine supplementation and the abdominal fat thicknes
142 cts were observed during the three months of berberine supplementation.
143                                We found that berberine suppressed NF-kappaB activation induced by var
144                                 Furthermore, berberine suppresses the growth of human colon carcinoma
145  suggest that the ancient paper is richer in berberine than its modern counterpart.
146  beta-carboline harmine and the isoquinoline berberine, that ameliorated certain aspects of the DM1 p
147 ignificantly greater than that observed with berberine, the major constituent of the herb.
148 ovide the molecular basis for the ability of berberine to act as an anticancer and anti-inflammatory
149 y was to use a supplementary management with berberine to control hyperlipidemia.
150 rformance, cassava starch was complexed with berberine to form a nano-berberine-starch complex and ca
151 binding mechanism of the anticancer alkaloid berberine to the human telomeric G4 (d[AG3(T2AG3)3]), co
152 naturally occurring GQ stabilizing compound, berberine, to these non-canonical genetic structures usi
153                                              Berberine-treated OVX-periodontitis rats consistently sh
154                                 In parallel, berberine-treated OVX-periodontitis rats harbored a high
155 -related immune responses were attenuated in berberine-treated OVX-periodontitis rats with a lower se
156 udy in FSHD patient myoblasts indicated that berberine treatment reduced DUX4 expression and also exp
157 el and tail vein injection model showed that berberine treatment reduced tumor growth and lung metast
158 mography and histologic analyses showed that berberine treatment significantly reduced alveolar bone
159 s, subjects receiving 1000 mg twice a day of berberine ursodeoxycholate had significantly greater red
160                             We conclude that berberine ursodeoxycholate has a broad spectrum of metab
161 bo-controlled trial of two doses of HTD1801 (berberine ursodeoxycholate, an ionic salt of berberine a
162                  The proapoptotic effects of berberine were closely associated with both the MDM2 exp
163  Several Berberis medicinal plants producing berberine were found also to synthesize an inhibitor of
164 as other naturally derived products, such as berberine, which is used in traditional medicine.
165                       The primary metabolite Berberine, which was qualitatively detected by GC-MS in
166 d by a SEM experiment showing the binding of berberine with one of the nucleoside derivatives, which

 
Page Top